Catalog #CP215

RecombiMAb anti-mouse CD20 (LALA-PG)

Clone MB20-11-CP215
Reactivities Mouse
Applications ELISA
Western Blot
Flow Cytometry
Isotype Mouse IgG2a (LALA-PG), κ
(Switched from Mouse IgG2c, κ)

$560.00 - $7,581.50

$560.00 - $7.00

Choose an Option...
  • 25 mg - $7,581.50
  • 5 mg - $2,170.50
  • 1 mg - $560.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left
US Customers - Order within 15 hours, 48 minutes to receive by October 9.

Product Description

The MB20-11-CP215 monoclonal antibody is a recombinant, chimeric version of the original MB20-11 antibody. The variable domain sequences are identical to clone MB20-11, but the constant region has been converted from mouse IgG2c to mouse IgG2a. Additionally, the constant region includes the Fc silencing mutation variant LALA-PG, rendering MB20-11-CP215 unable to bind endogenous murine Fcγ receptors or C1q to induce target cell depletion through antibody-dependent cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). This is useful when the desired effect is blocking or labeling CD20+ B cells without depletion, comparing B cell depletion vs B cell blockade, or eliminating confounding Fc‑mediated effects in combination studies. Fc-silent antibodies can also improve in-vitro assays by reducing non-specific signaling and background. The LALA-PG variant has demonstrated significantly reduced effector function, C1q binding and C3 fixation compared to other common silencing mutations while retaining favorable biophysical and manufacturing properties and preserving FcRn-mediated half-life. The highly controlled sequence and lack of genetic drift in recombinant antibodies provide more reliable and reproducible results over hybridoma derived antibodies.

MB20-CP215 binds mouse CD20, a ~33–37 kDa, B‑cell–restricted transmembrane protein expressed from the late pre‑B/immature stage through mature B cells but lost on plasma cells. CD20 modulates BCR‑driven calcium fluxes and optimizes activation and T‑independent responses without being essential for development. CD20 is widely used as a lineage marker and therapeutic target. CD20 blockade is a versatile tool for dissecting B‑cell biology and optimizing CD20‑targeted immunotherapies in preclinical models.

Specifications

Isotype Mouse IgG2a (LALA-PG), κ
Recommended Isotype Control(s) RecombiMAb mouse IgG2a (LALA-PG) isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Mutations LALA-PG
Immunogen Mouse CD20-GFP transfected 300.19 cells
Reported Applications ELISA
Western Blot
Flow Cytometry
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from mammalian cell supernatant in an animal-free facility
Purification Protein A
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Additional Formats

  1. Catalog #BE0356
    InVivoMAb anti-mouse CD20 Read more
  2. Catalog #BP0356
    InVivoPlus anti-mouse CD20 Read more
  3. Catalog #CP062
    RecombiMAb anti-mouse CD20 Read more